Bibliotecas PUC-SP - Busca Integrada

Adherence During Early Allergen Immunotherapy and Strategies to Motivate and Support Patients

Por Natalija Novak, Timo Buhl, Oliver Pfaar
Publicado no European Medical Journal (2018-09-01)

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio

Por Oliver Pfaar, Angelika Sager, Ralph Mösges, Margitta Worm
Publicado no Clinical and Translational Allergy (2023-11-01)

Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis

Por Oliver Pfaar, Ulrich Wahn, Giorgio Walter Canonica, Farah Bahbah, Philippe Devillier
Publicado no Clinical and Translational Allergy (2023-12-01)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis

Por Oliver Pfaar, Hartmut Richter, Angelika Sager, Christoph Miller, Thomas Müller, Marek Jutel
Publicado no Clinical and Translational Allergy (2023-05-01)

Subcutaneous birch pollen allergen immunotherapy with a depigmented polymerized extract shows only sustained and long‐term efficacy in a subgroup of monosensitized adults and adole...

Por Natalija Novak, Margitta Worm, Petra Staubach, Marek Jutel, Angelika Sager, Oliver Pfaar
Publicado no Clinical and Translational Allergy (2022-10-01)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study

Por Oliver Pfaar, Heinz-Gerd Richter, Ludger Klimek, Jochen Sieber, Meike Hadler, Efstrathios Karagiannis
Publicado em 2015-01-01

Barrier‐forming, drug‐free nasal spray reduces allergic symptoms induced by house dust mite allergen

Por Patricia Couroux, Nicole Grosse, Anne Marie Salapatek, Yasmeen Goyal, Oliver Pfaar, Ilja P. Hohenfeld
Publicado no Clinical and Translational Allergy (2023-07-01)

The treatment of mild upper respiratory tract infections – a position paper with recommendations for best practice

Por Andrew Smith, Peter Kardos, Oliver Pfaar, Winfried Randerath, Guillermo Estrada Riolobos, Fulvio Braido, Laura Sadofsky
Publicado no Drugs in Context (2023-07-01)

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology

Por Oliver Pfaar, Eckard Hamelmann, Ludger Klimek, Christian Taube, Christian Vogelberg, Martin Wagenmann, Thomas Werfel, Margitta Worm
Publicado no Clinical and Translational Allergy (2022-03-01)

Quality of life in type 2 and non‐type 2 endotypes in chronic rhinosinusitis with nasal polyps: A prospective trial

Por Stijn Bogaert, Elisabeth Rheindorf, Stefan Dazert, Stefan Volkenstein, Lisa Knipps, Jonas Jae‐Hyun Park, Oliver Pfaar
Publicado no Clinical and Translational Allergy (2025-06-01)

Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach

Por Oliver Pfaar, Anju T. Peters, Camille Taillé, Thijs Teeling, Jared Silver, Robert Chan, Peter W. Hellings
Publicado no Clinical and Translational Allergy (2025-01-01)

Atopic dermatitis occurrence and progression and allergen immunotherapy: A real-world, retrospective cohort study in Germany

Por Oliver Pfaar, MD, Hartmut Richter, Thomas Müller, PhD, Jasmin Weber, PhD, Angelika Sager, MD, Katja Nemat, MD
Publicado no World Allergy Organization Journal (2025-08-01)

Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation

Por Umit M. Sahiner, Mattia Giovannini, Maria M. Escribese, Giovanni Paoletti, Enrico Heffler, Montserrat Alvaro Lozano, Domingo Barber, Giorgio Walter Canonica, Oliver Pfaar
Publicado no Journal of Personalized Medicine (2023-05-01)

Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN study

Por Georg Boelke, Uwe Berger, Karl-Christian Bergmann, Carsten Bindslev-Jensen, Jean Bousquet, Julia Gildemeister, Marek Jutel, Oliver Pfaar, Torsten Sehlinger, Torsten Zuberbier
Publicado no Clinical and Translational Allergy (2017-09-01)

Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023

Por Oliver Pfaar, MD, Sven Becker, MD, MHBA, Christopher Calabria, MD, Diana Hartenstein, MD, Jenna Jung, MD, Julia Zimmer, PhD, Punita Ponda, MD
Publicado no World Allergy Organization Journal (2023-05-01)

Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a rando...

Por Antje Schuster, Davide Caimmi, Hendrik Nolte, Silviya Novakova, Jan Mikler, Majken Hougaard Foss-Skiftesvik, Anne Sofie Østerdal, Andrzej Emeryk, Remi Gagnon, Oliver Pfaar
Publicado no The Lancet Regional Health. Europe (2025-01-01)

First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients

Por Karl-Christian Bergmann, Linda Krause, Julia Hiller, Sylvia Becker, Sebastian Kugler, Martin Tapparo, Oliver Pfaar, Torsten Zuberbier, Matthias F. Kramer, Sonja Guethoff, Anke Graessel
Publicado no World Allergy Organization Journal (2021-01-01)

Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study

Por Bernardo Sousa-Pinto, Gilles Louis, Rafael José Vieira, Ana Margarida Pereira, Bilun Gemicioglu, Maciej Kupczyk, Violeta Kvedariene, Renaud Louis, Oliver Pfaar, João A. Fonseca, Torsten Zuberbier, Jean Bousquet
Publicado no Pulmonology (2025-12-01)

The need for Pan‐European automatic pollen and fungal spore monitoring: A stakeholder workshop position paper

Por Fiona Tummon, Lucas Alados Arboledas, Maira Bonini, Benjamin Guinot, Martin Hicke, Christophe Jacob, Vladimir Kendrovski, William McCairns, Eric Petermann, Vincent‐Henri Peuch, Oliver Pfaar, Michaël Sicard, Branko Sikoparija, Bernard Clot
Publicado no Clinical and Translational Allergy (2021-05-01)

Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real‐life

Por Oliver Pfaar, Hendrik Wolf, Rainer Reiber, André Knulst, Kirsten Sidenius, Mika J. Mäkelä, Sverre Steinsvåg, Christer Janson, Leonard van derZwan, Elena Uss, Peter Arvidsson, Kathrin Borchert, Helena Himmelhaus, Eike Wüstenberg
Publicado no Clinical and Translational Allergy (2024-07-01)